TENAYA THERAPEUTICS INC. - COMMON STOCK

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

17 12 2024 06:00:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024

16 12 2024 15:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

25 11 2024 07:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

19 11 2024 07:00:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

06 11 2024 15:05:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM

17 10 2024 15:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Participate in Upcoming Investment Conferences

03 9 2024 07:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

08 8 2024 15:05:01 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Announces Research Leadership Updates

27 6 2024 16:00:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit

18 6 2024 15:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

14 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting

02 5 2024 16:00:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

18 3 2024 15:05:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine

18 3 2024 07:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Participate in Upcoming March Investor Conferences

27 2 2024 15:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications

26 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Announces Pricing of Underwritten Offering

08 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

03 1 2024 07:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference

21 11 2023 15:30:00 提供 Nasdaq GlobeNewswire

Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

08 11 2023 15:05:00 提供 Nasdaq GlobeNewswire